SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-21-015234
Filing Date
2021-06-25
Accepted
2021-06-25 09:25:59
Documents
26

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 3083959
2 b_001.jpg GRAPHIC 7137
3 img_001.jpg GRAPHIC 107572
4 img_002.jpg GRAPHIC 135517
5 img_003.jpg GRAPHIC 206443
6 img_004.jpg GRAPHIC 144096
7 img_005a.jpg GRAPHIC 30167
8 img_005b.jpg GRAPHIC 24332
9 img_006.jpg GRAPHIC 65208
10 img_007.jpg GRAPHIC 159955
11 img_008.jpg GRAPHIC 181078
12 img_009.jpg GRAPHIC 73309
13 img_010.jpg GRAPHIC 107572
14 img_011.jpg GRAPHIC 115536
15 img_012.jpg GRAPHIC 55821
16 img_013.jpg GRAPHIC 106940
17 img_014.jpg GRAPHIC 167674
18 image_001.jpg GRAPHIC 50158
19 img_016.jpg GRAPHIC 23951
20 img_017.jpg GRAPHIC 114437
21 img_018.jpg GRAPHIC 98312
22 img_019.jpg GRAPHIC 90282
23 img_020.jpg GRAPHIC 107572
24 img_021.jpg GRAPHIC 135517
25 ima_021.jpg GRAPHIC 75841
26 b_002.jpg GRAPHIC 732
  Complete submission text file 0001493152-21-015234.txt   6344746
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 424B3 | Act: 33 | File No.: 333-257104 | Film No.: 211044906
SIC: 2834 Pharmaceutical Preparations